Purdue was not intended to thwart that process. Perhaps, this is why the Court has not found, and has not been pointed to, any decision extending Purdue's decision to § 363 sales. As the Supreme ...
Hosted on MSN3mon
McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid salesBOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the ...
Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback